Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC TAK-285 | HER2/EGFR inhibitor | 871026-44-7 | C26H25ClF3N5O3 | 1 ML
SDP

Catalog No. 5000374136
Encompass_Preferred

TAK-285 is a potent, selective, ATP-competitive, and orally active inhibitor of HER2 and EGFR (HER1), with IC50 values of 17 nM and 23 nM, respectively. It exhibits more than 10-fold selectivity for HER1/2 over HER4 and is less potent against MEK1/5, c-Met, Aurora B, Lck, and CSK. This compound demonstrates effective antitumor activity and can cross the blood-brain barrier (BBB).

  • Potent, selective, ATP-competitive, and orally active HER2 and EGFR (HER1) inhibitor
  • IC50 values: HER2: 17 nM; EGFR: 23 nM
  • Exhibits more than 10-fold selectivity for HER1/2 over HER4
  • Less potent against MEK1/5, c-Met, Aurora B, Lck, and CSK
  • Demonstrates effective antitumor activity
  • Can cross the blood-brain barrier (BBB)

Catalog No. 50-003-74136 Supplier Medchemexpress LLC Supplier No. HY1519610MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

TAK-285 is a potent, selective, ATP-competitive, and orally active inhibitor of HER2 and EGFR (HER1), with IC50 values of 17 nM and 23 nM, respectively. It exhibits more than 10-fold selectivity for HER1/2 over HER4 and is less potent against MEK1/5, c-Met, Aurora B, Lck, and CSK. This compound demonstrates effective antitumor activity and can cross the blood-brain barrier (BBB).

  • Potent, selective, ATP-competitive, and orally active HER2 and EGFR (HER1) inhibitor
  • IC50 values: HER2: 17 nM; EGFR: 23 nM
  • Exhibits more than 10-fold selectivity for HER1/2 over HER4
  • Less potent against MEK1/5, c-Met, Aurora B, Lck, and CSK
  • Demonstrates effective antitumor activity
  • Can cross the blood-brain barrier (BBB)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.